Authors

House Call

Dr. Aman Buzdar discusses the latest breast cancer treatment strategies with aromatase inhibitors.

Giving Is in Her DNA

An Extraordinary Healer essay honoring CAROL J. STALZER, B.S.N., RN, CBCN [UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER, HOUSTON, TEXAS]

Helping Me "Take Charge" After Cancer

An Extraordinary Healer essay honoring Sarah Rowe, RN, OCN [ Florida Cancer Affiliates in Panama City, Florida ]

No Stomach For Cancer Hosts Spotlight on Gastric Cancer Event in April

Stomach cancer non-profit organization hosts "Hereditary Diffuse Gastric Cancer: The past, the present, and hope for the future" event.

Starting Early and Staying Late: Dedication to Patients With Cancer

An Extraordinary Healer essay honoring Kim-Chi Pham, RN, OCN [Harris Health System – Lyndon B. Johnson General Hospital in Houston, Texas]

Chan Zuckerberg Initiative Awards Fibrolamellar Cancer Foundation First Ever "Rare As One Network" Grant

The Chan Zuckerberg Initiative (CZI) announced that the Fibrolamellar Cancer Foundation (FCF) is among a select group of patient-led rare disease organizations, including rare cancer foundations, to receive the first CZI Rare As One Network grant.

Standing Up to Cancer Means Not Letting It Steal My Joy

Standing up to cancer means focusing on the blessings, reveling in good news, and living life to its fullest every day.

Novel Drug Induces Robust Responses in von-Hippel Lindau Disease-Associated Kidney Cancer

At a median follow-up of almost two years, 88.5% of patients remained on study treatment.

Participating in a Lung Cancer Registry Can Be Empowering

Lung cancer registries, like the Bonnie J. Addario Lung Cancer Foundation's, can be beneficial to patients and researchers.

Who Should Be Tested for a BRCA Mutation? The Science Is Evolving

Clinical genetics experts see value in testing more women for BRCA mutations.

Compassionate Cancer Care That Began With a Hug

An Extraordinary Healer essay honoring Annie Nelson, RN, MSN [ Sanford Cancer Center and Center for Digestive Health in Sioux Falls, South Dakota ]

Caring for the Cancer Caregiver

Those acting as caregivers to patients with cancer often face their own set of hardships.

Managing Cancer Scares During a Pandemic

Navigating the scary path of a cancer caregiver possibly becoming the patient with cancer.

In Her Own Words

For Zora Brown, breast cancer was a journey that began before she was born.

Colleen M. O'Leary on How Patients Can Manage Oral Mucositis

Colleen M. O'Leary, RN, MSN, AOCNS, from The James Cancer Hospital, The Ohio State University, discusses how patients can manage oral mucositis.

More Than A Survivor: Stories of Warriors

Two-Drug Combo Improves Post-Transplant Myeloma Outcomes

A two-drug regimen improved outcomes for patients with myeloma when given before a stem cell transplant.

How Do I Get Her?

Winning Essay: CURE's 2008 Extraordinary Healer Award for Oncology Nursing

Defining Cancer Survivorship

When does a patient become a survivor of cancer? Some believe it’s at the moment of diagnosis, but others disagree.

Every Time I Think I Have Cancer

You know that saying “when you are sick, the internet is not your friend”? Well, that’s a fact. I start looking up runny nose, and because I believe that the runny substance coming from my nose must be spinal fluid, I must have brain cancer.

Journaling Through Confinement

An author who journaled while homebound after cancer treatment has created a book of writing prompts for those who are staying put during the COVID-19 pandemic.

Nanotechnology-Enabled Cancer Treatments and Diagnostics

The National Cancer Institute launched its Alliance for Nanotechnology in Cancer with the goal of using nanomedicine to change the way cancer is treated.

Bladder Cancer Advocacy Network Shines Spotlight on Common, But Unknown Killer

Front-Line Imbruvica-Venclexta Combo May Induce Durable Responses in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Treatment with this combination was associated with encouraging clinical responses in this patient population.

The Administration's Drug Rebate Proposal: An Opportunity to Put Patients First

Of all the health care regulations coming out of the current administration, the recent drug rebate proposal presents a new opportunity to significantly lower out-of-pocket prescription drug costs for Medicare patients. But like most things in health care, there is more complexity to the administration’s proposed changes to pharmaceutical company rebates than initially meets the eye.

When "Motivational" Isn't Motivational in Cancer

Examining the Safety of CLL Medication

OVER THE LAST FEW years, significant advances were made in the treatment of patients with chronic lymphocytic leukemia (CLL). Several novel therapies, most of them oral, have now been approved by the Food and Drug Administration. These include Imbruvica (ibrutinib), a Bruton’s tyrosine kinase (BTK) inhibitor; Venclexta (venetoclax), a B-cell lymphoma-2 (BCL2) inhibitor; and Zydelig (idelalisib), a phosphoinositide 3-kinase (PI3K) inhibitor.

One Million and Counting ... in Support of Bladder Cancer Research

When my late husband John and I started the Bladder Cancer Advocacy Network (BCAN) in 2005, our goal was not only to raise awareness about bladder cancer, but to change the landscape for this disease by funding research to discover new treatments that will save lives.

Web Tools Help Men Deal with Side Effects of Cancer Treatment

An online tool is designed to help men with prostate or other types of cancer deal with sexual dysfunction and other common side effects of treatment.

Looking At Yourself Differently After Cancer

Moment by moment, we move toward life. We feel what needs to be felt. We can even feel through the numb parts—the broken pieces. Instead of looking somewhere else, we look straight on— at ourselves and others. We see what’s really there. Who is there for us? Who is not? We choose to be with those we love, and those who love us back—like the person in the mirror, the new friend.